July 31, 2018 5:29pm

As I had stated, “Is the sector “collateral damage” from tech stocks?”

The next question, do the upticks set the stage for the Q2 reporting season launching Wednesday

After the last session of the month, review July’s journey …

 

Pre-open indications: 5 hits and 0 miss

 

Consider the end-of-day results as a next day primer!

Never leave an investor uninformed!  Want to know WHY, WHAT and HOW, 


Henry’omics:

The downside trend has been stymied after the FANG stocks took a beating with finally the oversold became a safer haven!

  • Investors should be concerned that the wall-of-worry could be anticipating more DOWNSIDE ahead despite today’s uptick.

Don’t remove the stop/loss or create them – NOW!

  • Tuesday was the last trading day of July and the major averages posted solid monthly gains. The Dow (+4.7%) and S&P 500 (+3.6%) rose, their biggest monthly gains since January. The Dow gained 5.8% in January while the S&P 500 rose 5.6% back then. The NASDAQ climbed more than 2% in July and notched its 4th straight monthly gain.

 

Of the 45 companies covered on Tuesday; 15 downside equities finished in a range of -$0.01 (IONS) to -$1.81 (ALNY) while the 28 upside equities oscillated from +$0.02 (PSTI) to $3.70 (RGNX) with 2 flat closes.

 

From the pre-open newsletter: “last session of the month with Q2 “earnings” on its tail. Is the sector “collateral damage” from tech stocks? RISK is still a four letter profanity.”

I also stated, “I actually don’t have anything to say … let the cards fall as they may; I am not holding any significant advantage in reviewing the sector this a.m. but, I did write … about the IBB - UPSIDE needed!”

Anomalies in volume trading of the downside with low volume: to the upside = ADRO, BTX and OSIR; downside with higher volume were = RENE.L, CLBS, AGTC, CUR and HSGX.

 

Biostage (BSTG) closed down -$0.26 or -7.24% to $3.33 (2,126 shares traded) after Monday’s $3.59 (800 shares traded) and last Friday’s $3.60 (4,400 shares traded) having started July at $4.52 – my OPINION – should happen to this group of “reverse splitters” leaving MANY investors deep in the pool of sludge!

  • Live with day trades, dive with them together – notice how many real firms have invested - NONE!

 

The advance/decline line scenario of 45 covered companies:   

  • The open was positive with an A/DL of 28/17 and 2 flats;
  • The mid-day continued positive with an A/DL of 33/10 and 2 flats;
  • The close was positive with an A/DL of 28/15 and 2 flat;

 

Pre-open to close indications: 5 hits and 0 miss

  • Asterias Biosciences (NYSEMKT: AST) closed up +$0.15 – hit;
  • Athersys (ATHX) closed up +$0.12 – hit;
  • CRISPR Therapeutics (CSP) closed up +$0.59 – trade, hit;
  • Editas Medicine (EDIT) closed up +$0.33 – trade, hit;
  • Intellia Therapeutics (NTLA) closed up +$0.83 – trade, hit;

 

MY working trend (5 largest) lines:

… The greatest volume to the downside:  MDXG, BLUE, ALNY, IONS and SAGE

… Upside volume was weighted to:  BTX, SGMO, ADRO, VSTM and GBT

… Leadership to the downside:  ALNY (-$1.81), RENE.L (-$1.38), SAGE (-$0.97), CLLS (-$0.96) and AXGN (-$0.38)

… Best moves to the upside:  RGNX (+$3.70), ONCE (+$3.54), SLDB (+$1.80), RARE (+$1.56) and GBT (+$1.35)

… Flats:  ADVM and MESO

 

The weekly count - decliners versus gainers – looks at the percentage (%) view from a different angle:

……. look at the differences in decliners:

  • Tuesday’s decliners ranged from -0.02% <IONS -$0.01 > to -7.24% <BSTG -$0.26> in 15 equities;
  • Monday’s decliners ranged from -0.28% <BSTG -$0.01 > to -7.37% <ALNY -$7.70 > in 30 equities;
  • Friday’s decliners ranged from -0.79% <PSTI -$0.01 > to -13.54% <MDXG -$0.65 > in 38 equities;
  • Thursday’s decliners ranged from -0.11% <FATE -$0.01 > to -6.87% < HSGX -$0.16 > in 28 equities;
  • Wednesday’s decliners ranged from -0.06% < ONCE -$0.05> to -13.51% <BSTG -$0.52 > in 16 equities;
  • Last Tuesday’s decliners ranged from -0.22% <KOOL -$0.009 > to -10.44% <FATE -$1.14 > in 40 equities;

Versus

… Look at the percentage’s (%) and spreads …

  • Tuesday’s gainers ranged from +0.49% <BCLI +$0.02 > to +9.37% <AST +$0.15 > in 28 equities;
  • Monday’s gainers ranged from +0.30% <CRSP +$0.14> to +7.21% <CUR +$0.08> in 12 equities;
  • Friday’s gainers ranged from +0.10% <OSIR <+$0.01 > to +4.35% <BSTG +0.15 > in 5 equities;
  • Thursday’s gainers ranged from +0.10% <BMRN +$0.10 > to +10.85% <MDXG +$0.47> in 14 equities;
  • Wednesday’s gainers ranged from +0.23% <BCLI +$0.01 > to +9.62% <MDXG +$0.38 > in 24 equities;
  • Last Tuesday’s gainers ranged from +1.71% <IONS +$0.76 > to +4.40% < BCLI +$0.18> in 4 equities;

 

Daily analytics and metrics:

  • The Dow rose +0.32% or +81.74 points to close at 25,388,
  • The S&P 500 rose +4.9% or 13.69 points,
  • The NASDAQ climbed +0.55% or +41.78 points,

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market:

  • Tuesday traded at 12.83, up +10.03%
  • Monday traded at 14.26, up +9.44%
  • Friday traded at 13.03, up +7.33%
  • Thursday traded at 12.14, down – 1.22%
  • Wednesday traded at 12.29, down -0.12%
  • Last Tuesday traded at 12.41, down -1.66%

 

The iShares Russell 2000 (IWM) closed:

  • Tuesday was up +1.07%;
  • Monday was down -0.65 %;
  • Friday was down -1.85%;
  • Thursday was up +0.51%;
  • Wednesday was up +0.37%;
  • Last Tuesday was down -1.06%;

 

The iShares NASDAQ Biotechnology (IBB) closed:

  • Tuesday was up +2.07%
  • Monday was down -1.11%
  • Friday was down -2.07%
  • Thursday was down -1.24%
  • Wednesday was up +1.11%
  • Last Tuesday was down -0.14%

 

JULY sessions:

Tuesday (last day) closed POSITIVE with 15 decliners, 28 advancers and 2 flat;

Monday (7/30) closed NEGATIVE with 30 decliners, 12 advancers and 3 flat;

Friday closed NEGATIVE with 38 decliners, 5 advancers and 2 flat;

Thursday closed NEGATIVE with 26 decliners, 14 advancers and 5 flat;

Wednesday closed POSITIVE with 16 decliners, 24 advancers and 5 flat;

Tuesday closed NEGATIVE with 40 decliners, 4 advancers and 1 flat;

Monday (7/23) closed NEGATIVE with 25 decliners, 18 advancers and 2 flats;

Last Friday closed NEGATIVE with 24 decliners, 15 advancers and 5 flats;

Thursday closed POSITIVE with 14 decliners, 28 advancers and 2 flats;

Wednesday closed NEGATIVE with 30 decliners, 13 advancers and 2 flat;

Tuesday closed POSITIVE with 13 decliners, 29 advancers and 3 flat;

Monday (7/16) closed NEGATIVE with 32 decliners, 10 advancers and 3 flat;

Friday closed POSITIVE with 17 decliners, 25 advancers and 3 flat;

Thursday closed POSITIVE with 19 decliners, 24 advancers and 2 flat;

Wednesday closed POSITIVE with 18 decliners, 24 advancers and 3 flat;

Tuesday closed NEGATIVE with 29 decliners, 15 advancers and 1 flat;

Monday (7/9) closed POSITIVE with 18 decliners, 22 advancers and 5 flat;

Friday closed POSITIVE with 8 decliners, 35 advancers and 2 flat;

Thursday closed POSITIVE with 18 decliners, 23 advancers and 4 flat;

Wednesday (7/4) was a holiday;

Tuesday closed POSITIVE with 9 decliners, 33 advancers and 3 flat;

Monday (7/2) closed POSITIVE with 15 decliners, 27 advancers and 3 flat;

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.